OTC Pharmaceuticals - Southern Africa

  • Southern Africa
  • Revenue in the OTC Pharmaceuticals market in Southern Africa amounts to US$1,125.00m in 2024.
  • The market is expected to grow annually by (CAGR 2024-2029).
  • The market's largest market is Cold & Cough Remedies with a market volume of US$233.30m in 2024.
  • In global comparison, the in the United States generates the most revenue with US$41,240.00m in 2024.
  • In relation to the total population, per person revenues of US$16.06 are generated in 2024.
  • In the OTC Pharmaceuticals market, 18.63% of total revenue will be generated through online sales by 2024.
  • In Southern Africa, the OTC Pharmaceuticals market is experiencing a growing demand for natural remedies and herbal supplements.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Southern Africa has been experiencing steady growth in recent years, driven by a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in Southern Africa have played a significant role in the development of the OTC Pharmaceuticals market. Consumers in the region have shown a growing preference for self-medication and over-the-counter remedies for common ailments. This shift in consumer behavior can be attributed to factors such as convenience, cost-effectiveness, and a desire for greater control over one's own health. As a result, there has been an increased demand for OTC pharmaceutical products in Southern Africa.Trends in the OTC Pharmaceuticals market have also contributed to its growth in Southern Africa. One notable trend is the increasing availability and accessibility of OTC products. Pharmacies and retail outlets have expanded their product offerings to cater to the growing demand, making it easier for consumers to access OTC medications. Additionally, there has been a rise in the number of private label OTC brands, offering consumers more affordable options without compromising on quality.Local special circumstances have further fueled the development of the OTC Pharmaceuticals market in Southern Africa. The region has a high burden of communicable diseases, such as malaria and HIV/AIDS, which has led to an increased need for OTC medications to manage symptoms and provide relief. Additionally, the lack of access to healthcare in some rural areas has made OTC medications a vital resource for individuals who are unable to seek medical attention for minor ailments.Underlying macroeconomic factors have also played a role in the growth of the OTC Pharmaceuticals market in Southern Africa. The region has experienced steady economic growth in recent years, resulting in an increase in disposable income and a growing middle class. This has led to higher healthcare spending and an increased willingness to invest in OTC medications for self-care. Furthermore, government initiatives to improve healthcare infrastructure and increase access to affordable healthcare have also contributed to the growth of the OTC Pharmaceuticals market.In conclusion, the OTC Pharmaceuticals market in Southern Africa has been developing due to customer preferences for self-medication, market trends such as increased availability and accessibility, local special circumstances including a high burden of communicable diseases, and underlying macroeconomic factors such as economic growth and government initiatives. These factors have created a favorable environment for the growth of the OTC Pharmaceuticals market in Southern Africa.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)